CLOSED - Clinical Trial on Facial Atopic Dermatitis & Atopic Keratoconjunctivitis Clinical Trial on Facial Atopic Dermatitis & Atopic Keratoconjunctivitis
Description
A local research facility is seeking participants for a clinical research study on Facial Atopic Dermatitis and Atopic Keratoconjunctivitis (AKC). The purpose of this clinical study is to see how effective an investigational medication is at helping to treat a condition known as atopic keratoconjunctivitis, or AKC. AKC presents as red, itchy eyes and eyelids and is commonly seen in patients with facial eczema that affects the eyes and/or eyelids. The study medication is currently FDA-approved to treat several inflammatory conditions and is being explored as a new therapy option for patients with AKC.
Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1575 for 7 visits or $2475 for 11 visits for time and travel.
Space is limited, subject to availability. Criteria for qualification are subject to change at any time and without notice.
Other focus groups:
